vitiligo
VITILIGO
Vitiligo is an acquired, often familial, melanocytopenic disorder that produces focal depigmentation of the skin.
About half of the patients has onset of lesion before the age of 20.
It is a progressive disease wherein spontaneous repigmentation may occur within 6 months.
Precipitating factors include emotional stress, sunburn, chemical exposure, skin trauma, inflammation, irritation or rash that may precede the lesions by 2-3 months.
Lesions are white-colored macules or patches with well-defined borders and otherwise normal skin surface.

Follow Up

Nonsegmental Vitiligo

  • NSV patients on narrow band UVB therapy should be reassessed on the 3rd & 6th mth of therapy
  • If still w/ disease progression after 3 mth of narrow band UVB therapy w/ topical steroid/calcineurin inhibitor therapy, consider switching to systemic corticosteroid therapy
    • After 3-6 mth, consider surgical interventions if disease is stable but w/o repigmentation, or depigmentation therapy if w/o repigmentation & w/ Koebner phenomenon
    • After 9 mth of narrow band UVB treatment, consider surgical interventions if disease is stable but repigmentation stopped

Segmental Vitiligo

  • Reassess patients on topical steroids & calcineurin inhibitors on the 6th mth of therapy
Editor's Recommendations
Most Read Articles
08 Aug 2017
More rapid diagnosis of calciphylaxis is possible with radiologic imaging when skin biopsy specimen is pending or not available, according to a recent study.
18 Aug 2017
The use of pulsed dye laser (PDL) in the treatment of acne vulgaris and acne erythema in young adults yields no significant improvement, but leads to high satisfaction among patients, according to a study.
09 Jul 2017
Studies in dermatology journals report harm quite well, according to a systematic review, adding that efforts should be made on reporting harm severity.